Picoplatin: Additional Phase II data

Additional data from a Phase II trial in 29 evaluable patients showed that picoplatin in combination with docetaxel and prednisone

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE